SPI Infoamtion

1. Industry Overview

1.1 Industry Definition
1.2 Scope of Study

2. Market Analysis

National Health Care Expenditure
Home Health Care Expenditure

3. Market Segment Analysis

3.1 Home Respiratory Therapy
3.1.1 Growth Factors

Sleep Apnea
Demand of Respiratory Therapy Equipment

3.2 Home Infusion Therapy
3.2.1 Growth Factors

Cost Advantage
Technological Trend

3.3 Durable Medical Equipment
3.3.1 Growth Factors

New Technologies
Aging Population

3.4 Home dialysis Market
3.4.1 Driving Factors (Home Hemodialysis)

Increasing Prevalence of Diabetes & Hypertension
Aging Population
Nocturnal Dialysis & Increase in Survival rates in Home Hemodialysis

4. Key Trends

Aging Population Drivi9ng Home Care
Increase in Employment Level
Rising Number of Home Healthcare Agencies
Cost Effectiveness

5. Major Challenges

Reimbursement Cuts for Medicare & Medicaid Services

6. Opportunities

New Intravenous drugs & Biologic Products
Growing Need of Aging Population
Increasing Awareness of Home Hemodialysis

7. Company Profiles

7.1 Invacare

Overview
Business Segment
Business Strategies
Product Innovation
Cost Reduction

7.2 American Homepatient Inc.

Overview
Business Segment
Business Strategies
Re-focusing on Sales & Marketing
Focus on Respiratory Services

7.3 NxStage

Overview
Business Segment
Business Strategies
Product Quality & Ease of Use
Acquisitions & Strategic Alliances

8. Market Outlook

8.1 Market Forecast

8.2 Forecast Methodology
8.2.1 Dependent and Independent Variables
8.2.2 Correlation analysis
8.2.3 Regression Analysis

List of Tables

Cost of Chemotherapy for Children with Cancer
US: Home & Center Dialysis Treatment in Thousand (2001-08)
Growth in Home & Center Dialysis Treatment (2001-08)
US Population Growth by Age Group (2000-20E)
Increasing Survival Rates in Home Treatment in Dialysis
Cost Comparison between Hospital & Home care
Mix of Medicare Oxygen Equipment & Monthly Payment Rates (2008)
Reduction in Average DME Payment Cut Due to Competitive Bidding (2008)
Revenue by Business Segment for Invacare (2007 & 2008)
Revenue by Business Segments for NxStage (2007 & 2008)
Revenue by Geographic Segments for NxStage (2007 & 2008)
Dependent & Independent Variables (2001- 2009)
Correlation Matrix
Model Summary - Coefficient of Determination
Regression Coefficients Output

List of Graphs

US: National Health Care Expenditure as a Percent of GDP
US: Home Health Care Expenditure (2004-08)
US: Number of Patients with OSA (2006A-11E)
US: Estimated Respiratory Market Size & COPD Share (2010E-15E)
US: Durable Medical Equipment Expenditure (2004-08)
US: Population Aged 65 & More (2006A-15E)
US: Number of Diabetic Cases (2008-13E)
US: Patients for Home (Home Hemodialysis) (2009E-12E)
US: Patients for Home (Peritoneal Hemodialysis) (2009E-12E)
US: Age Group 65 & More Population Growth (2004-08)
Home Health Care Services: Total Employment in the US (2002-07)
US: Home Care Agencies Growth (2001-07)
US: Patients for Home Treatment (2009E-12E)
US: Patients for Home Treatment (Remaining Opportunity) (2009E-12E)
US: Home Healthcare Expenditure Forecast (2008A-13E)
US: Durable Medical Equipment Expenditure (2009E-18E)
US: Breakup of National Health Expenditure in 2008 (%)
US: Breakup of Home Healthcare Expenditure in 2008 (%)
Home Medical Equipment & Services Segments (%): (2008)
Invacare: NA/HME: Revenue by Product (2008)
Invacare: Europe: Revenue by Product (2008)
Invacare: Asia/Pacific: Revenue by Product (2008)
American Homepatient: Revenue by Business Segment (2008)